Abstract
The U.S. Food and Drug Administration released draft guidance documents on human cells, tissues, and cellular and tissue-based products regulations. These proposed guidance documents can impact the practice of plastic surgery in the area of tissue grafting procedures. This article describes the relevant issues in these draft guidance documents, and presents the comments provided to the U.S. Food and Drug Administration by the American Society of Plastic Surgeons.
Original language | English (US) |
---|---|
Pages (from-to) | 1259-1261 |
Number of pages | 3 |
Journal | Plastic and Reconstructive Surgery |
Volume | 139 |
Issue number | 5 |
DOIs | |
State | Published - May 1 2017 |
ASJC Scopus subject areas
- Surgery